MMWR. 2000;49:780-782
Becton Dickinson Biosciences (Sparks, Maryland) has issued a voluntary recall of a lot of isoniazid [INH] (drug lot no. 9335260) used for antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis. The recalled INH lot was sold as components of BACTECT* S.I.R.E. kits (lot nos. 9327296, 9342298, and 9327298) and as individual drug for reconstitution (BACTECT Isoniazid kit lot no. 9327297) during January 2000–August 25, 2000.
The recall was issued following customer complaints and subsequent investigations by the manufacturer that found that vials of streptomycin may have been labeled inadvertently as the recalled lot of INH. A second lot of INH (drug lot no. 0077261) that was implicated initially is no longer involved in the recall. In the original complaint involving lot no. 0077261, the incorrect lot number was reported to the manufacturer. This recall does not affect other sources of INH used for AST or for therapeutic purposes.
Laboratories . . . [Full Text of this Article]
